Posted on

cbd oil parkinson’s disease

In fact, we’re funding a clinical trial through our Virtual Biotech right now. In a world first clinical trial, Professor Sagnik Bhattacharyya and Dr Latha Velayudhan at Kings College London (KCL) will be testing whether cannabidiol (CBD) can treat Parkinson’s psychosis symptoms.

We’ve now analysed their answers and produced a short report sharing our key findings.

Our survey results

When it comes to evidence of the benefits of cannabis-based products for people with Parkinson’s, the jury is definitely out.

Cannabis-based products are not available on prescription for people living with Parkinson’s. And using cannabis to help with your Parkinson’s symptoms is not a valid defence in the eyes of the law.

However, 87% of people who hadn’t used cannabis-derived products said they would want a doctor or pharmacist to prescribe them.

CBD is a compound found in the cannabis plant. Unlike another component, THC, CBD is non-addictive and doesn’t cause intoxication. You may have already heard of it because of its potential as a treatment for epilepsy and multiple sclerosis.

A biotech is a company that uses the latest technology and expertise to take the best scientific discoveries and turn them into new medical treatments.

What’s CBD?

In a world first clinical trial, researchers will test whether cannabidiol (CBD) can treat Parkinson’s psychosis symptoms with the help of the Virtual Biotech.

The Parkinson’s Virtual Biotech is our best chance of turning promising discoveries into real treatments for people with Parkinson’s.

This project is the first clinical trial to go through the Virtual Biotech and the 6th project overall.

You also can use a medical marijuana card to obtain CBD in some states. Nevertheless, a few states currently forbid the use of CBD. Check to see if CBD is legal in your state here.

CBD is a compound derived from the cannabis plant and is commonly sold in oils and foods. Depending on the product, CBD could potentially treat pain, anxiety, depression, insomnia, and inflammation, among other issues. Additionally, research suggests that CBD potentially could be useful for other conditions, including improving well-being and quality of life in Parkinson’s disease (PD).

Why is CBD controversial?

According to a 2018 review study published by the journal Frontiers in Pharmacology, “Cannabidiol is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects.” Data also suggest that CBD could potentially play a protective role in the treatment of certain movement disorders. Results are promising, but further studies are needed to clarify the efficacy of CBD.

Unlike tetrahydrocannabinol (THC), CBD generally has relaxing effects. Users do not feel “stoned” or intoxicated.

Has CBD helped you in any way? Please share in the comments below.